Integral Health Asset Management »

Glaukos shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Glaukos (GKOS) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Glaukos

Tip: Access up to 7 years of quarterly data

All positions including Glaukos held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glaukos by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.2M 100k 81.55
2025-06-30 $5.2M 50k 103.29
2020-09-30 $2.0M 40k 49.53

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Glaukos

BlackRock
Vanguard Group
Wellington Management Company
PRIMECAP Management Company
State Street Corporation
Ameriprise Financial
Alliancebernstein
Geode Capital Management
Westfield Capital Management Company
William Blair Investment Management
Henderson Group
Millennium Management
Capital World Investors
Braidwell
Brown Capital Management

View all funds holding Glaukos